Senti Biosciences engineers sophisticated gene circuits into allogeneic natural killer (NK) cells to create smart, off-the-shelf cell therapies for cancer. Their platform uses multi-gene calibrated circuits that enable immune cells to sense tumor microenvironment signals and respond with multiple therapeutic payloads, improving specificity for solid tumors.